Theu Duheron
Analyst
Get their honest, personalized take on your startup.
Sign in to pitch Theu →At a glance
- Full Name
- Théo Duheron (spelled "Théo Duhéron" in some French deal press)
- Title
- Analyst (Private Equity Analyst)
- Firm
- NiXEN Partners
- Firm Type
- Private equity — small- and mid-cap buyout (LBO), co-investment and fund-of-funds. *(Note: the stub's "Angel Investors" label does not match the sources; NiXEN is an AMF-approved mid-market buyout manager, not an angel/seed investor.)*
- Investment Stage
- Buyout / LBO (co-investment alongside lead sponsors), plus primary fund-of-funds commitments — not seed. *(Stub's "Seed Round" appears inaccurate.)*
- Check Size
- Equity tickets of roughly €1–10M per co-investment (firm-level)
- Target Company Profile
- Established, profitable small- and mid-cap companies undergoing buyouts, backed alongside reputable lead sponsors
- Sector Focus
- Sector-agnostic across the French/European mid-market; portfolio spans healthcare/pharma (CDMO), engineering & consulting, consumer/retail, and services
- Geographic Focus
- France and Europe (some global exposure via co-investment)
- Location
- Paris, France (57 Rue Pierre Charron / 38B Rue d'Artois, 75008 Paris)
Background
Théo Duheron works as an analyst at NiXEN Partners, an independent Paris-based private equity management company approved by France's financial regulator (AMF). NiXEN specializes in co-investment operations and primary commitments in the small- and mid-cap buyout (LBO) segment, and has accompanied 45+ participations over roughly two decades. As an analyst, Duheron sits within a small investment team (which has included partners and managing directors such as Priti Agarwal-Marteil and Sébastien Guillin) supporting deal sourcing, financial analysis, and transaction execution.
Duheron is a graduate of / featured alumnus of the Master Ingénierie Financière (Financial Engineering) program at Université Paris 1 Panthéon-Sorbonne (Ingéfi Sorbonne), one of France's top-ranked financial-engineering masters, where he was listed as a Private Equity Analyst at NiXEN Partners on the program's alumni/team page. This academic background in financial engineering — modeling, valuation, and structuring — is consistent with an analyst role in leveraged-buyout investing.
On the deal side, French M&A press (CFNEWS) records Duheron among the NiXEN-side participants in the 2019 sale of Vulcain Ingénierie, an engineering-consulting firm, to Equistone Partners — a "third LBO" transaction that valued the business at approximately €220M. NiXEN had held Vulcain since a 2014 LBO and remained a co-investor through subsequent ownership changes (the company later moved to Ardian in 2024). This places Duheron's work squarely in NiXEN's core small/mid-cap buyout activity rather than in angel or seed-stage investing.
Note on identity: the LinkedIn slug `theoduheron` has surfaced with an "Egis" (engineering group) tag in some search snippets, suggesting a possible career move or a spelling-similar individual; this could not be independently confirmed, so only his sourced NiXEN role is stated here.
Investment Thesis & Focus
- Firm mandate (NiXEN): "co-investment operations as well as primary investments in the small- and mid-cap buyout segments," done "alongside reputable funds, with guaranteed investments to secure the best projects."
- Stage: Control/minority positions in buyouts (LBOs) of established, cash-generative companies — not early-stage venture or seed.
- Structure: Two complementary strategies — (1) co-investment directly into deals led by established GPs, and (2) a fund-of-funds / primary program to build "a balanced strategy and a diversified portfolio."
- Ticket size: Equity investments in the ~€1–10M range per co-investment at the firm level.
- Sectors: Generalist across the European mid-market — pharma/CDMO, engineering & technical consulting, consumer, retail, and business services.
- Geography: Primarily France and broader Europe.
- As an analyst, Duheron supports (rather than leads) investment decisions — deal screening, financial modeling, due diligence, and monitoring — so the "yes" is driven by NiXEN's partners and the quality of the lead sponsor and target.
Notable Investments
- Vulcain Ingénierie — Engineering/technical consulting firm (energy, oil & gas, pharma, transport). NiXEN co-investor from 2014; Duheron named on the NiXEN side in the 2019 sale to Equistone (~€220M valuation); later sold to Ardian (2024).
- Unither — Pharmaceutical CDMO and world leader in blow-fill-seal (BFS) sterile unit-dose technology; NiXEN co-invested alongside Keensight Capital to back international expansion.
- CEVA — Portfolio holding listed by NiXEN.
- Palex — Medical-technology distribution group in NiXEN's portfolio.
- Historic NiXEN names: Buffalo Grill, La Grande Récré, Carré Blanc, Babeau-Seguin, Weave — illustrating the firm's consumer/retail and services buyout footprint.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.